Brainwave Biotechnology Profile
Key Indicators
- Authorised Capital ₹ 3.35 Cr
- Paid Up Capital ₹ 2.41 Cr
- Company Age 26 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 12.67%
- Profit Growth 25.19%
- Ebitda 27.88%
- Net Worth -6.83%
- Total Assets -7.74%
About Brainwave Biotechnology
Brainwave Biotechnology Private Limited (BBPL) is a Private Limited Indian Non-Government Company incorporated in India on 28 October 1998 and has a history of 26 years and three months. Its registered office is in Chennai, Tamil Nadu, India.
The Corporate was formerly known as Brainwave Biotechnology Limited. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 3.35 Cr and a paid-up capital of Rs 2.41 Cr, as per Ministry of Corporate Affairs (MCA) records.
Valli Arun and Nakkeeran Ekambaram serve as directors at the Company.
Company Details
-
Location
Chennai, Tamil Nadu, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U72300TN1998PTC041321
-
Company No.
041321
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
28 Oct 1998
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Chennai
Industry
Who are the key members and board of directors at Brainwave Biotechnology?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nakkeeran Ekambaram
|
Director | 18-Dec-2019 | Current |
|
Valli Arun
|
Director | 05-Apr-2002 | Current |
Financial Performance of Brainwave Biotechnology.
Brainwave Biotechnology Private Limited, for the financial year ended 2016, experienced significant growth in revenue, with a 12.67% increase. The company also saw a substantial improvement in profitability, with a 25.19% increase in profit. The company's net worth dipped by a decrease of 6.83%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Brainwave Biotechnology?
In 2017, Brainwave Biotechnology had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Valingro Private LimitedValli Arun is a mutual person
-
Southern India Chamber Of Commerce & IndustryValli Arun is a mutual person
-
Spel Semiconductor LimitedNakkeeran Ekambaram is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Brainwave Biotechnology?
Brainwave Biotechnology has a workforce of 0 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Brainwave Biotechnology, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Brainwave Biotechnology's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
